Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

A study showed that a greater percentage of patients with type 2 diabetes treated with the fixed–dose combination ACTOplus met as initial therapy reached the study goal of hemoglobin A1c of <=7 percent compared to either component alone. Safety and tolerability of ACTOplus met therapy were evaluated by rate of drug discontinuation and treatment–emergent adverse events.

   

Today in Popular Press...keeping you current

Pathological gambling may be successfully treated with medications for substance addiction
EurekAlert, 12/11/09

How calorie-restricted diets fight obesity and extend life span
EurekAlert, 12/10/09

Approved Drug may Slow Type 1 Diabetes
Ivanhoe, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address